226 related articles for article (PubMed ID: 35456557)
1. Efficacy and Safety of Intravitreal Fluocinolone Acetonide Implant for Chronic Diabetic Macular Edema Previously Treated in Real-Life Practice: The REALFAc Study.
Mathis T; Papegaey M; Ricard C; Rezkallah A; Matonti F; Sudhalkar A; Vartin C; Dot C; Kodjikian L
Pharmaceutics; 2022 Mar; 14(4):. PubMed ID: 35456557
[TBL] [Abstract][Full Text] [Related]
2. Fluocinolone Acetonide Intravitreal Implant 190 μg (ILUVIEN®) in Vitrectomized versus Nonvitrectomized Eyes for the Treatment of Chronic Diabetic Macular Edema.
Pessoa B; Coelho J; Correia N; Ferreira N; Beirão M; Meireles A
Ophthalmic Res; 2018; 59(2):68-75. PubMed ID: 29248913
[TBL] [Abstract][Full Text] [Related]
3. Outcomes in diabetic macular edema switched directly or after a dexamethasone implant to a fluocinolone acetonide intravitreal implant following anti-VEGF treatment.
Rehak M; Busch C; Unterlauft JD; Jochmann C; Wiedemann P
Acta Diabetol; 2020 Apr; 57(4):469-478. PubMed ID: 31749051
[TBL] [Abstract][Full Text] [Related]
4. A novel intravitreal fluocinolone acetonide implant (Iluvien(®)) in the treatment of patients with chronic diabetic macular edema that is insufficiently responsive to other medical treatment options: a case series.
Schmit-Eilenberger VK
Clin Ophthalmol; 2015; 9():801-11. PubMed ID: 25999689
[TBL] [Abstract][Full Text] [Related]
5. Three-Year Safety and Efficacy of the 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: The PALADIN Study.
Singer MA; Sheth V; Mansour SE; Coughlin B; Gonzalez VH
Ophthalmology; 2022 Jun; 129(6):605-613. PubMed ID: 35063472
[TBL] [Abstract][Full Text] [Related]
6. Early adoption of the fluocinolone acetonide (FAc) intravitreal implant in patients with persistent or recurrent diabetic macular edema (DME).
McCluskey JD; Kaufman PL; Wynne K; Lewis G
Int Med Case Rep J; 2019; 12():93-102. PubMed ID: 31114396
[No Abstract] [Full Text] [Related]
7. Rapid Structural and Functional Improvements with the 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Patients with DME and Low Visual Acuity: 6-Month Data from the UAE.
Elbarky AM
Clin Ophthalmol; 2020; 14():823-830. PubMed ID: 32214793
[TBL] [Abstract][Full Text] [Related]
8. Diabetic macular edema outcomes in eyes treated with fluocinolone acetonide 0.2 µg/d intravitreal implant: real-world UK experience.
El-Ghrably I; Steel DHW; Habib M; Vaideanu-Collins D; Manvikar S; Hillier RJ
Eur J Ophthalmol; 2017 May; 27(3):357-362. PubMed ID: 28165610
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal Fluocinolone Acetonide Implant (FAc, 0.19 mg, ILUVIEN®) in the Treatment of Patients with Recurrent Cystoid Macular Edema After Pars Plana Vitrectomy.
Lima-Fontes M; Leuzinger-Dias M; Barros-Pereira R; Fernandes V; Falcão M; Falcão-Reis F; Rocha-Sousa A; Alves-Faria P
Ophthalmol Ther; 2023 Feb; 12(1):377-388. PubMed ID: 36417092
[TBL] [Abstract][Full Text] [Related]
10. Case Series Investigating the Efficacy and Safety of Bilateral Fluocinolone Acetonide (ILUVIEN(®)) in Patients with Diabetic Macular Edema.
Elaraoud I; Attawan A; Quhill F
Ophthalmol Ther; 2016 Jun; 5(1):95-104. PubMed ID: 26885863
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of fluocinolone acetonide intravitreal implant in diabetic macular edema patients considered insufficiently responsive to available therapies (REACT): a prospective, non-randomized, and multicenter study.
Ruiz-Moreno JM; Adán A; Lafuente M; Asencio Durán M; Arias Barquet L; García Layana A; Araiz Iribarren J
Int Ophthalmol; 2023 Dec; 43(12):4639-4649. PubMed ID: 37697082
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and tolerability of the fluocinolone acetonide implant in patients with diabetic macular edema in UAE: 12-Month results.
Elbarky AM
Eur J Ophthalmol; 2021 Nov; 31(6):3196-3202. PubMed ID: 33426902
[TBL] [Abstract][Full Text] [Related]
13. Real-World Evidence of the Long-Term Effectiveness of 0.2 μg/Day Fluocinolone Acetonide Implant in Persistent and Recurrent Diabetic Macular Edema - A Single Center Study.
Soares RM; Ferreira CC; Fernandes JDS; Madeira C; Silva LMA; Saraiva E; Ribeiro L; Fonseca S
Clin Ophthalmol; 2024; 18():1057-1066. PubMed ID: 38646183
[TBL] [Abstract][Full Text] [Related]
14. Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes.
Coelho J; Malheiro L; Melo Beirão J; Meireles A; Pessoa B
Clin Ophthalmol; 2019; 13():1751-1759. PubMed ID: 31571814
[TBL] [Abstract][Full Text] [Related]
15. Real-world experience with fluocinolone acetonide intravitreal implant in patients with diabetic macular edema.
Capone L; Airaghi P; Aragona P; Castellino N; Cicinelli MV; Ciucci F; Coppola M; Gaetano C; Lattanzio R; Lorusso M; Maceroni M; Malvasi ME; Marco L; Marraffa M; Martini G; Mastropasqua R; Minnella AM; Nikolopulou E; Ortisi E; Pacella E; Papa V; Pennesi C; Reibaldi M; Rizzo S; Toto L; Trombetta L; Bandello F
Eur J Ophthalmol; 2024 Feb; ():11206721241235266. PubMed ID: 38396370
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of sustained-delivery fluocinolone acetonide intravitreal implant in patients with chronic diabetic macular edema insufficiently responsive to available therapies: a real-life study.
Massin P; Erginay A; Dupas B; Couturier A; Tadayoni R
Clin Ophthalmol; 2016; 10():1257-64. PubMed ID: 27468222
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomy.
Meireles A; Goldsmith C; El-Ghrably I; Erginay A; Habib M; Pessoa B; Coelho J; Patel T; Tadayoni R; Massin P; Atorf J; Augustin AJ
Eye (Lond); 2017 May; 31(5):684-690. PubMed ID: 28085139
[TBL] [Abstract][Full Text] [Related]
18. Treatment of refractory diabetic macular edema with a fluocinolone acetonide implant in vitrectomized and non-vitrectomized eyes.
La Mantia A; Hawrami A; Laviers H; Patra S; Zambarakji H
Int J Ophthalmol; 2018; 11(12):1951-1956. PubMed ID: 30588429
[TBL] [Abstract][Full Text] [Related]
19. Optical Coherence Tomography Biomarkers of Inflammation in Diabetic Macular Edema Treated by Fluocinolone Acetonide Intravitreal Drug-Delivery System Implant.
Arrigo A; Capone L; Lattanzio R; Aragona E; Zollet P; Bandello F
Ophthalmol Ther; 2020 Dec; 9(4):971-980. PubMed ID: 32914324
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of diabetic macular edema treated with dexamethasone implant: a real-life study.
Mathis T; Lereuil T; Abukashabah A; Voirin N; Sudhalkar A; Bilgic A; Denis P; Dot C; Kodjikian L
Acta Diabetol; 2020 Dec; 57(12):1413-1421. PubMed ID: 32656710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
